Amgen Dismisses Bone Density Concerns Related to Its New Weight-Loss Drug
(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...
Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don’t understand about obesity
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
verywellhealth22h
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
New Scientist22h
Weight-loss medications may also ease chronic pain
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...